scispace - formally typeset
D

Daniele Nuti

Researcher at University of Siena

Publications -  51
Citations -  2331

Daniele Nuti is an academic researcher from University of Siena. The author has contributed to research in topics: Benign paroxysmal positional vertigo & Nystagmus. The author has an hindex of 25, co-authored 50 publications receiving 1841 citations.

Papers
More filters
Journal ArticleDOI

Benign paroxysmal positional vertigo: Diagnostic criteria

TL;DR: The operational diagnostic criteria for benign paroxysmal positional vertigo (BPPV) were formulated by the Committee for Classification of Vestibular Disorders of the Barany Society as discussed by the authors.
Journal ArticleDOI

Benign Paroxysmal Positional Vertigo of the Horizontal Canal: A Form of Canalolithiasis with Variable Clinical Features

TL;DR: Benign paroxysmal positional vertigo of the horizontal semicircular canal (HC-BPPV) is a well-defined syndrome characterized by direction-changing horizontal positional nystagmus, and it is sustained that the clinical findings can be explained by movement of endolymph caused by displacement of otoconia in the semicircULAR canals.
Journal ArticleDOI

The management of horizontal-canal paroxysmal positional vertigo.

TL;DR: FPP was successful in more than 70% of patients; the barbecue rotation had slightly less successful but more immediate results; both methods enable otoconial debris to migrate into the posterior canal.
Journal ArticleDOI

The social impact of dizziness in London and Siena.

TL;DR: Factor analysis identified that detrimental effects on work, travel, social and family life combine to create a single factor accounting for much of the overall impact of patients' dizziness, with London patients often faring worse.
Journal ArticleDOI

Betahistine dihydrochloride in the treatment of peripheral vestibular vertigo.

TL;DR: The effective and safe profile of betahistine in the treatment of vertigo due to peripheral vestibular disorders was confirmed and both the physician's judgement and the patient's opinion on the efficacy and acceptability of the treatment were in agreement as to the superiority of bethistine.